Exhibit 1

Financial Ratios for Selected Consumer Products Companies

American Bristol-Myers Home Kimberly- Johnson & Procter & Gillette Squibb Products Clark Johnson Gamble (12/31/94) (12/31/94) (12/31/94) (12/31/94) (1/1/95) (6/30/95) 1. Profitability Ratios Profit margin Return on assets Return on equity 2. Activity Ratios Asset turnover Days' receivables Inventory turnover 3. Leverage Ratios Debt to equity Times interest earned Days' payables 4. Liquidity Ratios Current ratio Quick ratio 5. Market Ratios Price earnings ratio Dividend yield

11.50% 13.65% 39.93%

15.37% 15.06% 31.64%

17.04% 10.88% 37.59%

7.27% 9.35% 21.18%

12.75% 14.99% 31.62%

7.91% 10.95% 27.24%

114.57% 78 2.45

95.83% 59 2.30

61.07% 77 1.74

112.45% 39 6.23

112.75% 55 2.73

124.61% 36 6.20

1.72 27.29 183

1.26 38.57 77

4.09 18.65 64

1.59 7.29 25

1.20 19.88 67

1.66 9.20 50

1.54 0.80

1.57 1.04

1.69 0.94

0.88 0.42

1.57 0.77

1.25 0.66

26 1.39%

19 5.03%

15 4.52%

16 3.26%

20 2.26%

20 2.30%

Average of Six Companies

11.97% 12.48% 31.53%

103.55% 57 3.61

1.92 20.15 78

1.42 0.77

19 3.13%

Exhibit 2

Common Size Balance Sheets for Selected Consumer Products Companies

American Bristol-Myers Home KimberlyGillette Squibb Products Clark (12/31/94) (12/31/94) (12/31/94) (12/31/94) Total current assets Land, builidings and equipment Other assets Total assets Total current liabilities Long-term debt Deferred income taxes Other liabilities Total liabilities Common stock Retained earnings Common stock in treasury Cumulative foreign exchange earnings adjsutments Total equity Total liabilities and stockholders' equity Total assets ($ millions) 50.00% 25.68 24.32 100.0% 32.46% 13.01 3.40 14.42 63.29 11.12 51.51 -19.06 51.97% 28.40 19.63 100.0% 33.11% 4.99 17.72 55.82 3.49 58.87 -15.85 36.08% 17.59 46.33 100.0% 21.31% 46.01 4.50 8.55 80.37 5.18 14.89 0.00 26.95% 62.52 10.53 100.0% 30.66% 13.85 9.13 7.73 61.37 3.41 40.99 -1.15

-6.86 36.71 100.0% $ 5,494.0 $

-2.33 44.18 100.0% 12,910.0

-0.44 19.63 100.0% $ 21,674.0

-4.62 38.63 100.0% $ 6,716.0

Johnson & Procter & Average Johnson Gamble of Six (1/1/95) (6/30/95) Companies 42.63% 31.34 26.03 100.0% 27.23% 14.03 0.83 12.45 54.54 4.43 57.23 -15.98 38.55% 39.20 22.25 100.0% 30.75% 18.35 1.89 11.36 62.35 11.71 25.71 0.00 41.03% 34.12 24.85 100.0% 29.25% 18.37 3.29 12.04 62.95 6.56 41.53 -8.67

-0.22 45.46 100.0% $ 15,668.0

0.23 37.65 100.0% $ 28,125.0

-2.37 37.05 100.0%

Exhibit 3

Common Size Income Statements for Selected Consumer Products Companies

Gillette (12/31/94) Sales Costs and expenses Cost of sales SG&A Interest expense Total costs and expenses Operating income Other income Income before taxes Income taxes Income from continuing operations Discontinued operations Net earnings % of revenue by marketing segment 100.0%

Bristol-Myers Squibb (12/31/94) 100.0%

American Home Products (12/31/94) 100.0%

36.61 43.19 0.69 80.49 19.51 -1.32 18.19 6.69 11.50 0.00 11.50 Blades/ razors 39% Personal care 26% Stationery products 12% Household appliances 23%

26.05 53.33 0.57 79.95 20.05 1.27 21.32 5.95 15.37 0.00 15.37

31.18 44.54 1.28 77.00 23.00 -0.36 22.64 5.60 17.04 0.00 17.04

Pharmaceutical Health (58%) care (88%) Medical Food devices (14%) products (11%) Nonprescription Agricultural health (17%) (1%) Beauty aids (11%)

KimberlyClark (12/31/94) 100.0%

Johnson & Johnson (1/1/95) 100.0%

Procter & Gamble (6/30/95) 100.0%

Average of Six Companies 100.0%

66.88 22.00 1.75 90.63 9.37 0.69 10.06 3.76 6.30 -0.96 7.27

33.68 48.76 0.90 83.34 16.66 0.38 17.04 4.29 12.75 0.00 12.75 Laundry and cleaning Paper Beauty care Food and beverage Health care

58.69 28.81 1.46 88.96 11.04 0.92 11.96 4.05 7.91 0.00 7.91

42.18 40.11 1.11 83.40 16.61 0.26 16.87 4.06 11.81 -0.16 11.97

Disposable Consumer (33%) diapers (23%) Pharmaceutical Household (33%) tissue (24%) Professional Feminine care (34%) (10%) Other (43%)

(32%) (28%) (19%) (12%) (9%)

Exhibit 4

Income Statements for Selected Consumer Products Companies ($ in millions)

American Bristol-Myers Home KimberlyGillette Squibb Products Clark (12/31/94) (12/31/94) (12/31/94) (12/31/94) Sales Costs and expenses Cost of sales SG&A Interest expense Total costs and expenses Operating income Other income Income before taxes Income taxes Income from continuing operations Discontinued operations Net earnings $ 698 $ 1,842 $ 1,528 $ $ 6,070 $ 11,984 $ 8,966 $ 7,364

Johnson & Johnson (1/1/95) $ 15,734

2,222 2,622 42 4,886 1,184 -80 1,104 406 698

3,122 6,391 68 9,581 2,403 152 2,555 713 1,842

2,796 3,993 115 6,904 2,062 -32 2,030 502 1,528

4,925 1,620 129 6,674 690 51 741 277 464 -71 535 $

5,299 7,672 142 13,113 2,621 60 2,681 675 2,006

2,006

Procter & Gamble (6/30/95) $ 33,434

19,623 9,632 488 29,743 3,691 309 4,000 1,355 2,645

$

2,645

Exhibit 5

Balance Sheet for Selected Consumer Products Companies ($ in millions)

American Bristol-Myers Home KimberlyGillette Squibb Products Clark (12/31/94) (12/31/94) (12/31/94) (12/31/94) Total current assets Land, buildings and equipment Other assets Total assets Total current liabilities Long-term debt Deferred income taxes Other liabilities Total assets Common stock Retained earnigns Common stock in treasury Cumulative foreign exchange earnings adjsutments Total equity Total liabilities and stockholders' equity $ $ 2,747 $ 1,411 1,336 5,494 $ 1,783 $ 715 187 792 3,477 $ 611 2,830 -1,047 6,710 $ 7,821 $ 3666 3812 2534 10041 12,910 $ 21,674 $ 4,274 $ 644 4,618 $ 9,973 975 2,288 1,854 7,206 $ 17,420 $ 451 7,600 -2,046 1,123 3,226 1,810 4199 707 6,716 2,059 930 613 519 4,121 229 2,753 -77

$ $

$

-377 2,017 5,494 $

-301 5,704 12,910

-95 4,254 $ 21,674 $

-310 2,595 6,716

Johnson & Procter & Johnson Gamble (1/1/95) (6/30/95) $ 6,680 $ 10,842 4910 11,026 4078 6,257 15,668 $ 28,125 4,266 $ 8,648 2,199 5,161 130 531 1,951 3,196 8,546 $ 17,536 694 8,966 -2,503 3,293 7,231

$ $

$

-35 7,122 $ 15,668

65 10,589 $ 28,125

Exhibit 3

Common Size Income Statements for Selected Consumer Products Companies

1996 Sales Costs and expenses Cost of sales SG&A Interest expense Total costs and expenses Operating income Other income Income before taxes Income taxes Income from continuing operations Discontinued operations Net earnings % of revenue by marketing segment 635 8749

1995 8358

4451 3146 197 7794 955

4353 3436 205 7994 364

955 320 635

364 192 172

172

preffered stock dividend(net of related t weighteage avg no of shares EPS dividend pers share common stock- closing price

21.4 146.6 4.185539 1.88 92.25

21.6 145.2 1.035813 1.76 70.25

31-Dec-96 Total current assets Land, buildings and equipment Other assets Total assets Total current liabilities Long-term debt Deferred income taxes Other liabilities Total assets Common stock Retained earnigns Common stock in treasury Cumulative foreign exchange earnings adjsutments Total equity Total liabilities and stockholders' equity $ $ 2,372 2,429 3,100 7,901 1,904 2787 234 942 5,867 1678 2,360 -1469

31-Dec-95 $ 2,360 2,155 3,126 7,641 1,753 2992 237 980 5,962 1620 2,014 -1442

31-Dec-94 $ 2,178 1,988 1,977 6,142

$ $

$ $

$ $

$

$

1,529 1751.5 295.4 743.4 4,319.50 1612 2,113 -1462.4

-535 2,034 7,901 $

-513 1,679 7,641 $

-439.3 1,823 6,142

cash receivable (not of allowance) inventory accounts payable

248.2 1064.4 770.7 751.7

208.8 116.9 74.8 738.7

169.9 10496 713.9 694.9

1. Profitability Ratios Profit margin Return on assets Return on equity 2. Activity Ratios Asset turnover Days' receivables Inventory turnover 3. Leverage Ratios Debt to equity Times interest earned Days' payables 4. Liquidity Ratios Current ratio Quick ratio 5. Market Ratios Price earnings ratio Dividend yield

1996

1995

average of 6 companies

avg of 7 companies

7.257972 2.057909 9.69% 4.28% 34.2 9.82

11.97 12.48 31.53

10.14 11

1.13 $ 46 5.76

1.21 47 5.85

1.04 57 3.61

2.88 5.85 61.17

3.55 2.78 59.27

1.92 20.15 78

1.245798 1.346264

22.04017 67.82114 0.020379 0.025053

Sales

100.00

8358

Costs and expenses Cost of sales 4451 SG&A 3146 Interest expense 197 Total costs and expenses 7794 Operating income Other income 955

4353 3436 205 7994 364

Income before taxes 955 Income taxes 320

364 192 172

Income from continuing operations 635